Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	OLIENA Language recovery after stroke App | Video | PDF (278 pp) | Web

Hepatitis C

Free Subscription 23.12.2018 2 Ann Intern Med 1 Dig Dis Sci 2 Hepatology 1 J Hepatol 1 J Virol 3 Lancet Gastroenterol Hepatol 3 PLoS One

Retrieve available abstracts of this week’s articles: HTML format Text format

Single Articles

Ann Intern Med

1. ECKMAN MH, Woodle ES, Thakar CV, Paterno F, et al
   Transplanting Hepatitis C Virus-Infected or Uninfected Kidneys Into Hepatitis C Virus-Infected Recipients.
   Ann Intern Med. 2018;169:898-899.
   PubMed     Text format    
   
   
2. KIBERD B, Doucette K, Vinson A, Tennankore K, et al
   Transplanting Hepatitis C Virus-Infected or Uninfected Kidneys Into Hepatitis C Virus-Infected Recipients.
   Ann Intern Med. 2018;169:897-898.
   PubMed     Text format    
   
   

   
   Dig Dis Sci

3. SHETTY A, Buch A, Saab S
   Use of Hepatitis C-Positive Liver Grafts in Hepatitis C-Negative Recipients.
   Dig Dis Sci. 2018 Dec 17. pii: 10.1007/s10620-018-5404.
   PubMed     Text format     Abstract available
   
   

   
   Hepatology

4. SALMON-CERON D, Nahon P, Layese R, Bourcier V, et al
   HIV/HCV co-infected cirrhotic patients are no longer at higher risk for HCC or end-stage liver disease as compared to HCV mono-infected patients.
   Hepatology. 2018 Dec 19. doi: 10.1002/hep.30400.
   PubMed     Text format     Abstract available
   
   
5. WU J, Zhou Y, Fu X, Deng M, et al
   The burden of chronic hepatitis C in China from 2004 to 2050: an individual-based modeling study.
   Hepatology. 2018 Dec 18. doi: 10.1002/hep.30476.
   PubMed     Text format     Abstract available
   
   

   
   J Hepatol

6. DENOLLY S, Granier C, Fontaine N, Pozzetto B, et al
   A serum protein factor mediates maturation and apoB-association of HCV particles in the extracellular milieu.
   J Hepatol. 2018 Dec 13. pii: S0168-8278(18)32619.
   PubMed     Text format     Abstract available
   
   

   
   J Virol

7. LEBSIR N, Goueslain L, Farhat R, Callens N, et al
   Functional and physical interaction between the Arf activator GBF1 and hepatitis C virus NS3 protein.
   J Virol. 2018 Dec 19. pii: JVI.01459-18. doi: 10.1128/JVI.01459.
   PubMed     Text format     Abstract available
   
   

   
   Lancet Gastroenterol Hepatol

8. MULJONO DH
   Effective drugs on the road to HCV elimination and a therapeutic gap to close.
   Lancet Gastroenterol Hepatol. 2018 Dec 13. pii: S2468-1253(18)30417.
   PubMed     Text format    
   
   
9. GUPTA N, Mbituyumuremyi A, Kabahizi J, Ntaganda F, et al
   Treatment of chronic hepatitis C virus infection in Rwanda with ledipasvir-sofosbuvir (SHARED): a single-arm trial.
   Lancet Gastroenterol Hepatol. 2018 Dec 10. pii: S2468-1253(18)30382.
   PubMed     Text format     Abstract available
   
   
10. WEI L, Lim SG, Xie Q, Van KN, et al
    Sofosbuvir-velpatasvir for treatment of chronic hepatitis C virus infection in Asia: a single-arm, open-label, phase 3 trial.
    Lancet Gastroenterol Hepatol. 2018 Dec 13. pii: S2468-1253(18)30343.
    PubMed     Text format     Abstract available
    
    

    
    PLoS One

11. GUALERZI A, Bellan M, Smirne C, Tran Minh M, et al
    Improvement of insulin sensitivity in diabetic and non diabetic patients with chronic hepatitis C treated with direct antiviral agents.
    PLoS One. 2018;13:e0209216.
    PubMed     Text format     Abstract available
    
    
12. GALLACH M, Vergara M, da Costa JP, Miquel M, et al
    Impact of treatment with direct-acting antivirals on anxiety and depression in chronic hepatitis C.
    PLoS One. 2018;13:e0208112.
    PubMed     Text format     Abstract available
    
    
13. BILLA O, Chalouni M, Salmon D, Poizot-Martin I, et al
    Factors associated with non-AIDS-defining cancers and non HCV-liver related cancers in HIV/HCV-coinfected patients- ANRS-CO13 HEPAVIH cohort.
    PLoS One. 2018;13:e0208657.
    PubMed     Text format     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Hepatitis C is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: